Paper · 40076745
Anti-Bacterial and Anti-Inflammatory Properties of Sophoridine and Its Effect on Diarrhea in Mice.
Wang J and 6 others. Int J Mol Sci, 2025. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Anti-Bacterial and Anti-Inflammatory Properties of Sophoridine and Its Effect on Diarrhea in Mice. Papers, record 40076745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40076745
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-Bacterial and Anti-Inflammatory Properties of Sophoridine and Its Effect on Diarrhea in Mice.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents | Major topic |
| Alkaloids | Major topic |
| Anti-Bacterial Agents | Major topic |
| Quinolizines | Major topic |
| Diarrhea | Major topic |
| Animals | |
| Mice | |
| RAW 264.7 Cells | |
| Matrines | |
| Mice, Inbred BALB C | |
| Escherichia coli | |
| Cytokines | |
| Male | |
| Disease Models, Animal | |
| NF-kappa B |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022xjkk0404 | 'Third Xinjiang Scientific Expedition Program' supported by the Ministry of Science and Tech-nology of the People's Republic of China, 2022-2025 | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,798,551 | Inhibitory Effect of Two Traditional Chinese Medicine Monomers, Berberine and Matrine, on the Quorum Sensing System of Antimicrobial-Resistant Escherichia coli. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31798551 | PubMed |
| 2 | 33,937,093 | Gut Microbiota and Diarrhea: An Updated Review. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/33937093 | PubMed |
| 3 | 22,121,777 | [Sophoridine inhibits NF-kappaB signaling pathway activation in kidney tissue of endotoxemia mice]. | Yao Xue Xue Bao | 2011 | https://conductscience.org/library/papers/22121777 | PubMed |
| 4 | 30,743,078 | Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats. | Int Immunopharmacol | 2019 | https://conductscience.org/library/papers/30743078 | PubMed |
| 5 | 16,369,557 | Immune cell migration in inflammation: present and future therapeutic targets. | Nat Immunol | 2005 | https://conductscience.org/library/papers/16369557 | PubMed |
| 6 | 30,718,924 | IL-10 produced by macrophages regulates epithelial integrity in the small intestine. | Sci Rep | 2019 | https://conductscience.org/library/papers/30718924 | PubMed |
| 7 | 24,211,392 | Hymenaea stigonocarpa Mart. ex Hayne: A tropical medicinal plant with intestinal anti-inflammatory activity in TNBS model of intestinal inflammation in rats. | J Ethnopharmacol | 2014 | https://conductscience.org/library/papers/24211392 | PubMed |
| 8 | 31,575,657 | Sophoridine Inhibits Human Colorectal Cancer Progression via Targeting MAPKAPK2. | Mol Cancer Res | 2019 | https://conductscience.org/library/papers/31575657 | PubMed |
| 9 | 11,846,609 | Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. | Methods | 2001 | https://conductscience.org/library/papers/11846609 | PubMed |
| 10 | 33,718,223 | Sophoridine Inhibits the Tumour Growth of Non-Small Lung Cancer by Inducing Macrophages M1 Polarisation via MAPK-Mediated Inflammatory Pathway. | Front Oncol | 2021 | https://conductscience.org/library/papers/33718223 | PubMed |
1 to 10 of 60
See all 60 referencesCited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,797,923 | Sophora japonica Extract Supplementation Facilitates Piglets' Early Weaning Transition by Alleviating Intestinal Oxidative Stress, Inflammation, and Microbiota Dysbiosis. | Vet Sci | 2026 | https://conductscience.org/library/papers/42797923 | PubMed |
| 42,694,409 | Traditional Chinese medicine modulates tumor-associated macrophages to suppress gastric cancer progression: mechanisms and therapeutic potential. | Front Oncol | 2026 | https://conductscience.org/library/papers/42694409 | PubMed |
| 42,528,752 | Sophoridine attenuates osteoarthritis progression: association with suppression of chondrocyte pyroptosis via inhibiting NF-κB signaling pathway. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42528752 | PubMed |
| 41,974,989 | Sophflarines F-K: matrine-based alkaloids with a rare aromatic system from Sophora flavescens and their anti-inflammatory and synergistic antibacterial effects. | Nat Prod Bioprospect | 2026 | https://conductscience.org/library/papers/41974989 | PubMed |
| 40,612,058 | Mechanism of Shi-Yang-Xiao lotion in alleviating perianal eczema based on network pharmacology and experimental validation. | Front Mol Biosci | 2025 | https://conductscience.org/library/papers/40612058 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40076745
GET https://conductscience.org/api/papers/v1/40076745/references?page=2